Position in RCEL
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$11,717
+$2,478 QoQ
Shares Held
3,167
+18.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $1,711,271,467 across 97 Medical Devices names. RCEL ranks #83 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,712,243 | $381,135,988 | |
| 2 | BSX |
Boston Scientific Corp
|
5,101,806 | $320,138,326 | |
| 3 | SYK |
Stryker Corp
|
741,255 | $243,568,980 | |
| 4 | MDT |
Medtronic plc
|
2,518,123 | $218,195,357 | |
| 5 | DXCM |
Dexcom Inc
|
1,600,989 | $100,542,109 | |
| 6 | EW |
Edwards Lifesciences Corp
|
922,938 | $73,908,875 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
932,136 | $66,349,440 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
407,068 | $36,807,088 |
All Filings in RCEL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,717 | 3,167 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $9,239 | 2,678 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $14,757 | 2,888 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,870 | 2,622 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $69,613 | 8,552 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $37,836 | 2,956 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||